[Latest therapeutic strategy for stage IV non-small cell lung cancer].
Kawate
Norihiko
N
International University of Health and Welfare/Respiratory Disease Center, Sanno Hospital.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology / Q000628:therapy*; D002945:Cisplatin / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D000077156:Gefitinib; D006801:Humans; D006979:Hyperthermia, Induced; D007167:Immunotherapy; D008175:Lung Neoplasms / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D011799:Quinazolines / Q000627:therapeutic use; D011878:Radiotherapy; D015607:Stents
D004791:Enzyme Inhibitors; D011799:Quinazolines; D002945:Cisplatin; D000077156:Gefitinib